ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse

AMBRISENTANUM

Active substance (INN) · 0 products authorised in Romania

◀ Back

Protocols it appears in

As a medicine of the protocol (in the title) or only mentioned in the text

Code	Protocol	Status	Role	Sublist	GP
CI01I-HTP	Protocol terapeutic în hipertensiunea arterială pulmonară: SILDENAFILUM, BOSENTANUM, AMBRISENTANUM, MACITENTANUM, RIOCIGUAT	In force	medicine of the protocol	C2-P6.3	NO
B01AC21-HTAP	TREPROSTINILUM	In force	mentioned in the text	C2-P6.3	NO
B01AC21-HTAPCT	TREPROSTINILUM	In force	mentioned in the text	C2-P6.3	NO
B01AC27	SELEXIPAGUM	In force	mentioned in the text	C2-P6.3	NO

Authorised brand products (ANMDM)

The Romanian register of medicines for human use, updated daily

No product with this substance in the ANMDM register (a new medicine, or one authorised only centrally in the EU).

Data extracted automatically from the documents published by CNAS (cnas.ro/protocoale-terapeutice) and from the ANMDM medicines register. For information only; the official text (the Ministry of Health / CNAS orders published in the Official Gazette) prevails. Protocol names and texts are shown in Romanian, as published.